During the past decade, Illinois Retina Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois Retina Associates" #1 sponsor was "Allegro Ophthalmics, LLC" with 1 trials, followed by "Clearside Biomedical, Inc." with 1 trials sponsored, "Eyegate Pharmaceuticals, Inc." with 1 trials sponsored, "Gyroscope Therapeutics Limited" with 1 trials sponsored and "ThromboGenics" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois Retina Associates" #1 collaborator was "Duke University" with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator and "Trial Runners, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Illinois Retina Associates" are "Anterior Uveitis" (1 trials), "Dry Age-related Macular Degeneration" (1 trials), "Macular Edema" (1 trials), "Non-Proliferative Diabetic Retinopathy" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Illinois Retina Associates" in a lesser frequency.

Most popular intervention types in "Illinois Retina Associates" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "1.0mg Luminate®" (1 trials), "100 mM sodium citrate buffer solution" (1 trials), "2.0mg Luminate®" (1 trials), "3.0mg Luminate®" (1 trials) and "40 mg/mL Dexamethasone phosphate ophthalmic solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Illinois Retina Associates" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Illinois Retina Associates". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Illinois Retina Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois Retina Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".